Skip to main content

Table 4 Multivariate analysis of the effect of simvastatin in improving the survival

From: Survival benefits of adding simvastatin to standard therapy for secondary prevention of bleeding esophageal varices in patients with hepatitis C-related liver cirrhosis

  Multivariate
OR (95% CI) p-value
Encephalopathy 0.725 (0.352–1.652) 0.998
Survival 0.136 (0.020–0.916) 0.040*
Myalgia 5.812 (0.658–51.361) 0.113
Child score 4.419 (0.874–22.341) 0.072